Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141411 |
| CAS No | NA |
| Mol.F. | C10H13ClN2O : HCl |
| Mol.Wt. | 212.7 : 36.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141412 |
| CAS No | NA |
| Mol.F. | C10H12N2O |
| Mol.Wt. | 176.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141413 |
| CAS No | 500545-48-2 |
| Mol.F. | C15H26ClN3O2 |
| Mol.Wt. | 315.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141414 |
| CAS No | NA |
| Mol.F. | C3H9N3O3S |
| Mol.Wt. | 167.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141415 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141416 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N6O4 |
| Mol.Wt. | 559.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141417 |
| CAS No | NA |
| Mol.F. | C14H20N4O5 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141418 |
| CAS No | NA |
| Mol.F. | C25H28Cl2N6O5 |
| Mol.Wt. | 563.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141419 |
| CAS No | NA |
| Mol.F. | C26H30Cl2N6O5 |
| Mol.Wt. | 577.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141420 |
| CAS No | NA |
| Mol.F. | C25H26Cl2N6O4 |
| Mol.Wt. | 545.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141421 |
| CAS No | NA |
| Mol.F. | C21H18Cl2N4O4 |
| Mol.Wt. | 461.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141422 |
| CAS No | NA |
| Mol.F. | C34H26N4O6 |
| Mol.Wt. | 586.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141424 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141425 |
| CAS No | NA |
| Mol.F. | C18H17N5O |
| Mol.Wt. | 319.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141423 |
| CAS No | NA |
| Mol.F. | C13H17N3O5 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141426 |
| CAS No | NA |
| Mol.F. | C32H27N5O3 |
| Mol.Wt. | 529.6 |
| INV STATUS | CUSTOM SYNTHESIS |